Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Med Tech-related technology assessments and clinical guidelines from NICE in May 2020

12 Jun 2020

In May 2020, the National Institute for Health and Care Excellence (NICE) published only two new Medtech innovation briefings (for cytokine adsorption devices for treating respiratory failure in people with COVID-19 and space from Depression (SilverCloud) for treating adults with depression).

MedTech Innovation Briefing is the NICE's advice program for innovative technologies. It provides an overview of clinical effectiveness, safety, and cost. It does not offer formal guidance, and it, therefore, does not provide any recommendations.

Two new Medtech Innovation Briefings for Cytokine adsorption devices for treating respiratory failure in people with COVID-19 (the adsorption devices are cartridges containing adsorbent materials, such as porous polymer beads or resin) and Space from Depression for treating adults with depression (an online program used to treat depression, delivered with support and guidance from a therapist, as an alternative to face-to-face cognitive behavioral therapy) have been published in May.

See the full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.